Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Ampio Pharmaceuticals (AMPE) has a market cap of $2,951 Dollars USD. According to our data, Ampio Pharmaceuticals is ranked No.9324 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $2,951 Dollars |
-0.03%
|
| Dec 31, 2024 | $0.00 M |
-99.87%
|
| Dec 29, 2023 | $2.33 M |
-54.48%
|
| Dec 30, 2022 | $5.11 M |
-97.37%
|
| Dec 31, 2021 | $0.19 B |
-64.15%
|
| Dec 31, 2020 | $0.54 B |
172.73%
|
| Dec 31, 2019 | $0.20 B |
47.67%
|
| Dec 31, 2018 | $0.13 B |
-90.30%
|
| Dec 29, 2017 | $1.39 B |
352.12%
|
| Dec 30, 2016 | $0.31 B |
-67.38%
|
| Dec 31, 2015 | $0.94 B |
2.04%
|
| Dec 31, 2014 | $0.92 B |
-51.89%
|
| Dec 31, 2013 | $1.91 B |
98.61%
|
| Dec 31, 2012 | $0.96 B |
-15.93%
|
| Dec 30, 2011 | $1.15 B |
77.92%
|
| Dec 31, 2010 | $0.64 B |
60.00%
|
| Dec 31, 2009 | $0.40 B |
0.00%
|
| Dec 31, 2008 | $0.40 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Karyopharm Therapeutics
KPTI
|
$84.09 M |
0.000 M
|
USA
|
 Tiziana Life Sciences
TLSA
|
$82.74 M |
-0.000 M
|
UK
|
 Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
USA
|
 CytomX Therapeutics
CTMX
|
$65.57 M |
0.000 M
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
| Market Cap | = | AMPE Stock Price | * | AMPE Shares Outstanding |
| = | $0.00 | * | 1.14 M | |
| = | $2,951 Dollars |